WESTMINSTER, Colo.--(BUSINESS WIRE)--Reed Group, a leading provider of health and productivity solutions for employers, today announced the expansion of its MDGuidelines® product to help health systems improve outcomes and lower costs. This clinical decision support solution draws on Reed Group’s 30-year history working with employers and insurers to promote more informed decisions at the point of care and to help providers transition to value-based models.
Combining evidence-based clinical guidelines and physiological duration tables with electronic medical record (EMR) integration and analytics, this decision support solution helps reduce costly variations in care, assists in the development of optimal treatment plans and enables patients to return to health and normal activities safely and quickly.
“Building on Reed Group’s proven success in helping insurers and Fortune 500 companies improve healthcare outcomes by returning their members and employees to activity, this intelligent clinical decision support offering leverages our extensive experience and expertise to empower health systems to achieve similar goals,” said David Roberts, CEO of Reed Group. “Our expanded MDGuidelines solution addresses the unique needs of accountable care organizations and other healthcare providers as they manage both an increasing amount of regulations and financial risk in a rapidly changing marketplace.”
While evidence-based care is not new, recent studies show that the top concerns of healthcare C-suite executives include minimizing clinical variation, redesigning services for population health and controlling avoidable utilization. In addition, many providers still lack easy access to data-driven solutions that deliver actionable insights at the point of care.
Reed Group’s latest offering expands on the existing functionality of its widely-adopted MDGuidelines product to include evidence-based clinical guidelines, EMR integration, recovery timeframes, data analytics and benchmarking capabilities. The solution enables providers to identify optimal treatment plans and form accurate estimates of patient recovery times for illness and injury at the point of care. With the ability to view clinical best practices alongside patient history, providers can customize treatments and better engage patients in a dialogue about their recovery. Furthermore, having access to this information enables health systems to benchmark performance against real-world data, pinpoint specific opportunities for improvement and manage cases for optimal outcomes.
“Providers today are faced with a great deal of pressure to deliver higher quality care, improve outcomes and reduce costs for the populations they serve,” said Joe Guerriero, SVP of MDGuidelines. “This powerful, decision support tool brings together world-class clinical guidelines, physiological duration tables and data from millions of de-identified cases to deliver actionable insights at the point of care.”
Visit MDGuidelines.com for more information.
About Reed Group
Reed Group, Ltd., a wholly owned subsidiary of The Guardian Life Insurance Company of America®, is the trusted provider of clinical content, leading edge software, absence management outsourcing services and data analytics to employers, insurers and health care organizations. Reed Group serves its 3,000 customers with nearly 2,000 employees across multi-sites and global operations in U.S., Canada and India. For more information, visit www.reedgroup.com.